{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:28Z","timestamp":1792677628725,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K12 HS026385"],"award-info":[{"award-number":["K12 HS026385"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02830-7","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T16:03:23Z","timestamp":1710259403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis"],"prefix":"10.1007","volume":"316","author":[{"given":"Christy H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-399X","authenticated-orcid":false,"given":"Raj","family":"Chovatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"2830_CR1","doi-asserted-by":"publisher","DOI":"10.13188\/2373-1044.1000019","author":"LJ Borda","year":"2015","unstructured":"Borda LJ, Wikramanayake TC (2015) Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. https:\/\/doi.org\/10.13188\/2373-1044.1000019","journal-title":"J Clin Investig Dermatol"},{"issue":"5","key":"2830_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/exd.14091","volume":"29","author":"JA Adalsteinsson","year":"2020","unstructured":"Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J (2020) An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol 29(5):481\u2013489. https:\/\/doi.org\/10.1111\/exd.14091","journal-title":"Exp Dermatol"},{"key":"2830_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-3-319-33919-1_20","volume-title":"Dermatology in public health environments: a comprehensive textbook","author":"J de Avelar Breunig","year":"2018","unstructured":"de Avelar Breunig J, Couto MOR (2018) Seborrheic dermatitis. In: Bonamigo RR, Dornelles SIT (eds) Dermatology in public health environments: a comprehensive textbook. Springer International Publishing, pp 429\u2013447. https:\/\/doi.org\/10.1007\/978-3-319-33919-1_20"},{"issue":"9","key":"2830_CR4","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.12788\/jfp.0315","volume":"70","author":"CR Heath","year":"2021","unstructured":"Heath CR, Usatine RP (2021) Seborrheic dermatitis. J Fam Pract 70(9):E3\u2013E4. https:\/\/doi.org\/10.12788\/jfp.0315","journal-title":"J Fam Pract"},{"issue":"1","key":"2830_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-7753.82117","volume":"3","author":"S Ranganathan","year":"2011","unstructured":"Ranganathan S, Manuel F (2011) A new postulate on two stages of dandruff: a clinical perspective. Int J Trichology 3(1):3. https:\/\/doi.org\/10.4103\/0974-7753.82117","journal-title":"Int J Trichology"},{"issue":"3","key":"2830_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","volume":"55","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Lim HW, Margolis D et al (2006) The burden of skin diseases: 2004. J Am Acad Dermatol 55(3):490\u2013500. https:\/\/doi.org\/10.1016\/j.jaad.2006.05.048","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2830_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Dellavalle RP, Coffeng LE et al (2017) Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol 153(5):406\u2013412. https:\/\/doi.org\/10.1001\/jamadermatol.2016.5538","journal-title":"JAMA Dermatol"},{"key":"2830_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.861053","volume":"12","author":"Y Xue","year":"2022","unstructured":"Xue Y, Bao W, Zhou J et al (2022) Global burden, incidence and disability-adjusted life-years for dermatitis: a systematic analysis combined with socioeconomic development status, 1990\u20132019. Front Cell Infect Microbiol 12:861053. https:\/\/doi.org\/10.3389\/fcimb.2022.861053","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"2830_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/exd.14006","volume":"28","author":"TC Wikramanayake","year":"2019","unstructured":"Wikramanayake TC, Borda LJ, Miteva M, Paus R (2019) Seborrheic dermatitis\u2014looking beyond Malassezia. Exp Dermatol 28(9):991\u20131001. https:\/\/doi.org\/10.1111\/exd.14006","journal-title":"Exp Dermatol"},{"issue":"3","key":"2830_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/mmy.39.3.243.251","volume":"39","author":"AK Gupta","year":"2001","unstructured":"Gupta AK, Kohli Y, Summerbell RC, Faergemann J (2001) Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 39(3):243\u2013251. https:\/\/doi.org\/10.1080\/mmy.39.3.243.251","journal-title":"Med Mycol"},{"issue":"4","key":"2830_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","volume":"31","author":"C Dessinioti","year":"2013","unstructured":"Dessinioti C, Katsambas A (2013) Seborrheic dermatitis: etiology, risk factors, and treatments. Clin Dermatol 31(4):343\u2013351. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.01.001","journal-title":"Clin Dermatol"},{"issue":"5","key":"2830_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ijd.13116","volume":"55","author":"A Prohic","year":"2016","unstructured":"Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S (2016) Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol 55(5):494\u2013504. https:\/\/doi.org\/10.1111\/ijd.13116","journal-title":"Int J Dermatol"},{"issue":"2","key":"2830_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/myc.12276","volume":"58","author":"A Barac","year":"2015","unstructured":"Barac A, Pekmezovic M, Milobratovic D, Otasevic-Tasic S, Radunovic M, Arsic AV (2015) Presence, species distribution, and density of Malassezia yeast in patients with seborrhoeic dermatitis\u2014a community-based case-control study and review of literature. Mycoses 58(2):69\u201375. https:\/\/doi.org\/10.1111\/myc.12276","journal-title":"Mycoses"},{"issue":"5","key":"2830_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4014\/jmb.2012.12048","volume":"31","author":"M Park","year":"2021","unstructured":"Park M, Park S, Jung WH (2021) Skin commensal fungus Malassezia and its lipases. J Microbiol Biotechnol 31(5):637\u2013644. https:\/\/doi.org\/10.4014\/jmb.2012.12048","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"2830_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1087-0024.2005.10119.x","volume":"10","author":"YM DeAngelis","year":"2005","unstructured":"DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL (2005) Three etiologic facets of dandruff and seborrheic dermatitis: malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 10(3):295\u2013297. https:\/\/doi.org\/10.1111\/j.1087-0024.2005.10119.x","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"2830_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2307\/3761291","volume":"90","author":"LI Plotkin","year":"1998","unstructured":"Plotkin LI, Mathov I, Squiquera L, Leoni J (1998) Arachidonic acid released from epithelial cells by malassezia furfur phospholipase A2: a potential pathophysiologic mechanism. Mycologia 90(2):163. https:\/\/doi.org\/10.2307\/3761291","journal-title":"Mycologia"},{"issue":"2","key":"2830_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","volume":"30","author":"LJ Borda","year":"2019","unstructured":"Borda LJ, Perper M, Keri JE (2019) Treatment of seborrheic dermatitis: a comprehensive review. J Dermatol Treat 30(2):158\u2013169. https:\/\/doi.org\/10.1080\/09546634.2018.1473554","journal-title":"J Dermatol Treat"},{"key":"2830_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.614446","volume":"10","author":"SH Vijaya Chandra","year":"2021","unstructured":"Vijaya Chandra SH, Srinivas R, Dawson TL, Common JE (2021) Cutaneous Malassezia: commensal, pathogen, or protector? Front Cell Infect Microbiol 10:614446. https:\/\/doi.org\/10.3389\/fcimb.2020.614446","journal-title":"Front Cell Infect Microbiol"},{"issue":"7454","key":"2830_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12171","volume":"498","author":"K Findley","year":"2013","unstructured":"NIH Intramural Sequencing Center Comparative Sequencing Program, Findley K, Oh J et al (2013) Topographic diversity of fungal and bacterial communities in human skin. Nature 498(7454):367\u2013370. https:\/\/doi.org\/10.1038\/nature12171","journal-title":"Nature"},{"issue":"1","key":"2830_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1146\/annurev-micro-040820-010114","volume":"76","author":"G Ianiri","year":"2022","unstructured":"Ianiri G, LeibundGut-Landmann S, Dawson TL (2022) Malassezia: a commensal, pathogen, and mutualist of human and animal skin. Annu Rev Microbiol 76(1):757\u2013782. https:\/\/doi.org\/10.1146\/annurev-micro-040820-010114","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"2830_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5021\/ad.2009.21.1.18","volume":"21","author":"SJ Jang","year":"2009","unstructured":"Jang SJ, Lim SH, Ko JH et al (2009) The investigation on the distribution of Malassezia yeasts on the normal Korean skin by 26S rDNA PCR-RFLP. Ann Dermatol 21(1):18. https:\/\/doi.org\/10.5021\/ad.2009.21.1.18","journal-title":"Ann Dermatol"},{"key":"2830_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/13693780902977976","author":"T Sugita","year":"2009","unstructured":"Sugita T, Suzuki M, Goto S et al (2009) Quantitative analysis of the cutaneous Malassezia microbiota in 770 healthy Japanese by age and gender using a real-time PCR assay. Med Mycol. https:\/\/doi.org\/10.1080\/13693780902977976","journal-title":"Med Mycol"},{"issue":"2","key":"2830_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5021\/ad.2011.23.2.156","volume":"23","author":"YW Lee","year":"2011","unstructured":"Lee YW, Byun HJ, Kim BJ et al (2011) Distribution of Malassezia Species on the scalp in Korean seborrheic dermatitis patients. Ann Dermatol 23(2):156. https:\/\/doi.org\/10.5021\/ad.2011.23.2.156","journal-title":"Ann Dermatol"},{"issue":"2","key":"2830_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.jid.5701017","volume":"128","author":"M Tajima","year":"2008","unstructured":"Tajima M, Sugita T, Nishikawa A, Tsuboi R (2008) Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 128(2):345\u2013351. https:\/\/doi.org\/10.1038\/sj.jid.5701017","journal-title":"J Invest Dermatol"},{"key":"2830_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00157","author":"RC Soares","year":"2016","unstructured":"Soares RC, Camargo-Penna PH, De Moraes VCS et al (2016) Dysbiotic bacterial and fungal communities not restricted to clinically affected skin sites in dandruff. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2016.00157","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"2830_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5021\/ad.2010.22.2.149","volume":"22","author":"BH Oh","year":"2010","unstructured":"Oh BH, Lee YW, Choe YB, Ahn KJ (2010) Epidemiologic study of Malassezia yeasts in seborrheic dermatitis patients by the analysis of 26S rDNA PCR-RFLP. Ann Dermatol 22(2):149. https:\/\/doi.org\/10.5021\/ad.2010.22.2.149","journal-title":"Ann Dermatol"},{"issue":"3","key":"2830_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058203","volume":"8","author":"C Clavaud","year":"2013","unstructured":"Clavaud C, Jourdain R, Bar-Hen A et al (2013) Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS ONE 8(3):e58203. https:\/\/doi.org\/10.1371\/journal.pone.0058203","journal-title":"PLoS ONE"},{"issue":"4","key":"2830_CR28","first-page":"332","volume":"69","author":"IM Bergbrant","year":"1989","unstructured":"Bergbrant IM, Faergemann J (1989) Seborrhoeic dermatitis and Pityrosporum ovale: a cultural and immunological study. Acta Derm Venereol 69(4):332\u2013335","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"2830_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2133.1993.tb00480.x","volume":"129","author":"HR Ashbee","year":"1993","unstructured":"Ashbee HR, Ingham E, Holland KT, Cunliffe WJ (1993) The carriage of Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Br J Dermatol 129(5):533\u2013540. https:\/\/doi.org\/10.1111\/j.1365-2133.1993.tb00480.x","journal-title":"Br J Dermatol"},{"key":"2830_CR30","first-page":"1","volume":"167","author":"IM Bergbrant","year":"1991","unstructured":"Bergbrant IM (1991) Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol Suppl (Stockh) 167:1\u201336","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"issue":"1","key":"2830_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/CMR.15.1.21-57.2002","volume":"15","author":"HR Ashbee","year":"2002","unstructured":"Ashbee HR, Evans EGV (2002) Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 15(1):21\u201357. https:\/\/doi.org\/10.1128\/CMR.15.1.21-57.2002","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2830_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2133.1998.02310.x","volume":"139","author":"R-P Munoz-Perez","year":"1998","unstructured":"Munoz-Perez R-P, Camacho C (1998) Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol 139(1):33\u201339. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02310.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"2830_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0190-9622(92)70153-7","volume":"27","author":"JR Wikler","year":"1992","unstructured":"Wikler JR, Nieboer C, Willemze R (1992) Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 27(1):37\u201339. https:\/\/doi.org\/10.1016\/0190-9622(92)70153-7","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2830_CR34","doi-asserted-by":"publisher","first-page":"24877","DOI":"10.1038\/srep24877","volume":"6","author":"Z Xu","year":"2016","unstructured":"Xu Z, Wang Z, Yuan C et al (2016) Dandruff is associated with the conjoined interactions between host and microorganisms. Sci Rep 6(1):24877. https:\/\/doi.org\/10.1038\/srep24877","journal-title":"Sci Rep"},{"issue":"9","key":"2830_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/exd.13293","volume":"26","author":"T Park","year":"2017","unstructured":"Park T, Kim H, Myeong NR et al (2017) Collapse of human scalp microbiome network in dandruff and seborrhoeic dermatitis. Exp Dermatol 26(9):835\u2013838. https:\/\/doi.org\/10.1111\/exd.13293","journal-title":"Exp Dermatol"},{"issue":"5","key":"2830_CR36","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00449-020-02333-5","volume":"44","author":"Q Lin","year":"2021","unstructured":"Lin Q, Panchamukhi A, Li P et al (2021) Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis. Bioprocess Biosyst Eng 44(5):965\u2013975. https:\/\/doi.org\/10.1007\/s00449-020-02333-5","journal-title":"Bioprocess Biosyst Eng"},{"issue":"2","key":"2830_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/microorganisms9020353","volume":"9","author":"B De Pessemier","year":"2021","unstructured":"De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C (2021) Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms 9(2):353. https:\/\/doi.org\/10.3390\/microorganisms9020353","journal-title":"Microorganisms"},{"issue":"11","key":"2830_CR38","first-page":"14","volume":"2","author":"GK Kim","year":"2009","unstructured":"Kim GK (2009) Seborrheic dermatitis and Malassezia species: how are they related? J Clin Aesthetic Dermatol 2(11):14\u201317","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"2","key":"2830_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/bjd.14501","volume":"175","author":"MB Zani","year":"2016","unstructured":"Zani MB, Soares RC, Arruda ACBB, De Arruda LHF, Paulino LC (2016) Ketoconazole does not decrease fungal amount in patients with seborrhoeic dermatitis. Br J Dermatol 175(2):417\u2013421. https:\/\/doi.org\/10.1111\/bjd.14501","journal-title":"Br J Dermatol"},{"key":"2830_CR40","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2147\/CCID.S284671","volume":"15","author":"F Dall\u2019Oglio","year":"2022","unstructured":"Dall\u2019Oglio F, Nasca MR, Gerbino C, Micali G (2022) An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol 15:1537\u20131548. https:\/\/doi.org\/10.2147\/CCID.S284671","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2830_CR41","doi-asserted-by":"publisher","first-page":"CD008138","DOI":"10.1002\/14651858.CD008138.pub3","volume":"5","author":"EO Okokon","year":"2015","unstructured":"Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN (2015) Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev 5:CD008138. https:\/\/doi.org\/10.1002\/14651858.CD008138.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2830_CR42","doi-asserted-by":"publisher","first-page":"12086","DOI":"10.1038\/s41598-018-30588-2","volume":"8","author":"M Park","year":"2018","unstructured":"Park M, Cho YJ, Lee YW, Jung WH (2018) Understanding the mechanism of action of the anti-dandruff agent zinc pyrithione against Malassezia restricta. Sci Rep 8(1):12086. https:\/\/doi.org\/10.1038\/s41598-018-30588-2","journal-title":"Sci Rep"},{"issue":"4","key":"2830_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00403-006-0679-8","volume":"298","author":"F Liebel","year":"2006","unstructured":"Liebel F, Lyte P, Garay M, Babad J, Southall MD (2006) Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res 298(4):191\u2013199. https:\/\/doi.org\/10.1007\/s00403-006-0679-8","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2830_CR44","first-page":"125","volume":"74","author":"RA Schwartz","year":"2006","unstructured":"Schwartz RA, Janusz CA, Janniger CK (2006) Seborrheic dermatitis: an overview. Am Fam Physician 74(1):125\u2013130","journal-title":"Am Fam Physician"},{"issue":"4","key":"2830_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/0378-6323.178903","volume":"82","author":"A Mehta","year":"2016","unstructured":"Mehta A, Nadkarni N, Patil S, Godse K, Gautam M, Agarwal S (2016) Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol 82(4):371. https:\/\/doi.org\/10.4103\/0378-6323.178903","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"19","key":"2830_CR46","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"2830_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-10-4609-4_4","volume-title":"A treatise on topical corticosteroids in dermatology: use, misuse and abuse","author":"A Das","year":"2018","unstructured":"Das A, Panda S (2018) An evidence based approach of use of topical corticosteroids in dermatology. In: Lahiri K (ed) A treatise on topical corticosteroids in dermatology: use, misuse and abuse. Springer, pp 41\u201372. https:\/\/doi.org\/10.1007\/978-981-10-4609-4_4"},{"key":"2830_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-981-10-4609-4_2","volume-title":"A treatise on topical corticosteroids in dermatology: use, misuse and abuse","author":"G Kwatra","year":"2018","unstructured":"Kwatra G, Mukhopadhyay S (2018) Topical corticosteroids: pharmacology. In: Lahiri K (ed) A treatise on topical corticosteroids in dermatology: use, misuse and abuse. Springer, pp 11\u201322. https:\/\/doi.org\/10.1007\/978-981-10-4609-4_2"},{"issue":"2","key":"2830_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00128071-200910020-00003","volume":"10","author":"BA Cook","year":"2009","unstructured":"Cook BA, Warshaw EM (2009) Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. Am J Clin Dermatol 10(2):103\u2013118. https:\/\/doi.org\/10.2165\/00128071-200910020-00003","journal-title":"Am J Clin Dermatol"},{"key":"2830_CR50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27622","author":"O Alsmeirat","year":"2022","unstructured":"Alsmeirat O, Lakhani S, Egaimi M, Idris O, Elkhalifa M (2022) The efficacy and safety of pimecrolimus in patients with facial seborrheic dermatitis: a systematic review of randomized controlled trials. Cureus. https:\/\/doi.org\/10.7759\/cureus.27622","journal-title":"Cureus"},{"issue":"5","key":"2830_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2340\/00015555-1532","volume":"93","author":"T Kim","year":"2013","unstructured":"Kim T, Mun J, Jwa S et al (2013) Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial. Acta Derm Venereol 93(5):557\u2013561. https:\/\/doi.org\/10.2340\/00015555-1532","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"2830_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.5021\/ad.2015.27.5.523","volume":"27","author":"HO Kim","year":"2015","unstructured":"Kim HO, Yang YS, Ko HC et al (2015) Maintenance therapy of facial seborrheic dermatitis with 0.1% tacrolimus ointment. Ann Dermatol 27(5):523\u2013530. https:\/\/doi.org\/10.5021\/ad.2015.27.5.523","journal-title":"Ann Dermatol"},{"issue":"6","key":"2830_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamadermatol.2023.0846","volume":"159","author":"MJ Zirwas","year":"2023","unstructured":"Zirwas MJ, Draelos ZD, Du Bois J et al (2023) Efficacy of roflumilast foam, 0.3%, in patients with seborrheic dermatitis: a double-blind vehicle-controlled phase 2a randomized clinical trial. JAMA Dermatol 159(6):613. https:\/\/doi.org\/10.1001\/jamadermatol.2023.0846","journal-title":"JAMA Dermatol"},{"key":"2830_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.065","author":"A Blauvelt","year":"2024","unstructured":"Blauvelt A, Draelos ZD, Stein Gold L, Alonso-Llamazares J, Bhatia N, DuBois J, Forman SB, Gooderham M, Green L, Guenthner ST, Hebert AA, Lain E, Moore AY, Papp KA, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk DR, Chu DH (2024) Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: a randomized, double-blinded, vehicle-controlled, phase 3 trial. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.065","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2830_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","volume":"3","author":"M Wittmann","year":"2013","unstructured":"Wittmann M, Helliwell PS (2013) Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther 3(1):1\u201315. https:\/\/doi.org\/10.1007\/s13555-013-0023-0","journal-title":"Dermatol Ther"},{"key":"2830_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.017","author":"JM Jackson","year":"2022","unstructured":"Jackson JM, Alexis A, Zirwas M, Taylor S (2022) Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.017","journal-title":"J Am Acad Dermatol"},{"key":"2830_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/PTT.S303634","volume":"11","author":"M Milakovic","year":"2021","unstructured":"Milakovic M, Gooderham MJ (2021) Phosphodiesterase-4 inhibition in psoriasis. Psoriasis Targets Ther 11:21\u201329. https:\/\/doi.org\/10.2147\/PTT.S303634","journal-title":"Psoriasis Targets Ther"},{"issue":"1","key":"2830_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1203475419878162","volume":"24","author":"SR Cohen","year":"2020","unstructured":"Cohen SR, Gordon SC, Lam AH, Rosmarin D (2020) Recalcitrant seborrheic dermatitis successfully treated with apremilast. J Cutan Med Surg 24(1):90\u201391. https:\/\/doi.org\/10.1177\/1203475419878162","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"2830_CR59","first-page":"577","volume":"17","author":"D Liu","year":"2018","unstructured":"Liu D, Chow P, Strawn S, Rajpara A, Wang T, Aires D (2018) Chronic nasolabial fold seborrheic dermatitis successfully controlled with crisaborole. J Drugs Dermatol JDD 17(5):577\u2013578","journal-title":"J Drugs Dermatol JDD"},{"issue":"4","key":"2830_CR60","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1468-2494.2012.00723.x","volume":"34","author":"GA Turner","year":"2012","unstructured":"Turner GA, Hoptroff M, Harding CR (2012) Stratum corneum dysfunction in dandruff. Int J Cosmet Sci 34(4):298\u2013306. https:\/\/doi.org\/10.1111\/j.1468-2494.2012.00723.x","journal-title":"Int J Cosmet Sci"},{"issue":"5","key":"2830_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00403-002-0323-1","volume":"294","author":"CR Harding","year":"2002","unstructured":"Harding CR, Moore AE, Rogers SJ, Meldrum H, Scott AE, McGlone FP (2002) Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch Dermatol Res 294(5):221\u2013230. https:\/\/doi.org\/10.1007\/s00403-002-0323-1","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"2830_CR62","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1067\/mjd.2001.117849","volume":"45","author":"RR Warner","year":"2001","unstructured":"Warner RR, Schwartz JR, Boissy Y, Dawson TL (2001) Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 45(6):897\u2013903. https:\/\/doi.org\/10.1067\/mjd.2001.117849","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2830_CR63","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/ijms21082867","volume":"21","author":"G Yang","year":"2020","unstructured":"Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY (2020) Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int J Mol Sci 21(8):2867. https:\/\/doi.org\/10.3390\/ijms21082867","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2830_CR64","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ng1813","volume":"38","author":"RY Birnbaum","year":"2006","unstructured":"Birnbaum RY, Zvulunov A, Hallel-Halevy D et al (2006) Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein. Nat Genet 38(7):749\u2013751. https:\/\/doi.org\/10.1038\/ng1813","journal-title":"Nat Genet"},{"issue":"8","key":"2830_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042628","volume":"7","author":"I Cohen","year":"2012","unstructured":"Cohen I, Birnbaum RY, Leibson K, Taube R, Sivan S, Birk OS (2012) ZNF750 is expressed in differentiated keratinocytes and regulates epidermal late differentiation genes. PLoS ONE 7(8):e42628. https:\/\/doi.org\/10.1371\/journal.pone.0042628","journal-title":"PLoS ONE"},{"issue":"8","key":"2830_CR66","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/exd.13150","volume":"26","author":"TC Wikramanayake","year":"2017","unstructured":"Wikramanayake TC, Borda LJ, Kirsner RS et al (2017) Loss of MPZL3 function causes seborrhoeic dermatitis-like phenotype in mice. Exp Dermatol 26(8):736\u2013738. https:\/\/doi.org\/10.1111\/exd.13150","journal-title":"Exp Dermatol"},{"issue":"2","key":"2830_CR67","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1152\/ajpendo.00228.2013","volume":"305","author":"TA Czyzyk","year":"2013","unstructured":"Czyzyk TA, Andrews JL, Coskun T et al (2013) Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis. Am J Physiol-Endocrinol Metab 305(2):E282\u2013E292. https:\/\/doi.org\/10.1152\/ajpendo.00228.2013","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"7","key":"2830_CR68","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/jid.2014.94","volume":"134","author":"AG Leiva","year":"2014","unstructured":"Leiva AG, Chen AL, Devarajan P et al (2014) Loss of Mpzl3 function causes various skin abnormalities and greatly reduced adipose depots. J Invest Dermatol 134(7):1817\u20131827. https:\/\/doi.org\/10.1038\/jid.2014.94","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2830_CR69","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/sj.jid.5700706","volume":"127","author":"T Cao","year":"2007","unstructured":"Cao T, Racz P, Szauter KM et al (2007) Mutation in Mpzl3, a gene encoding a predicted the adhesion protein, in the rough coat (rc) mice with severe skin and hair abnormalities. J Invest Dermatol 127(6):1375\u20131386. https:\/\/doi.org\/10.1038\/sj.jid.5700706","journal-title":"J Invest Dermatol"},{"issue":"12","key":"2830_CR70","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/exd.13798","volume":"27","author":"TC Wikramanayake","year":"2018","unstructured":"Wikramanayake TC, Hirt P, Almastadi M et al (2018) Increased IL-17-expressing \u03b3\u03b4 T cells in seborrhoeic dermatitis-like lesions of the Mpzl3 knockout mice. Exp Dermatol 27(12):1408\u20131411. https:\/\/doi.org\/10.1111\/exd.13798","journal-title":"Exp Dermatol"},{"issue":"3","key":"2830_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 55(3):379\u2013390. https:\/\/doi.org\/10.1007\/s12016-018-8702-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"2830_CR72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/bjd.17826","volume":"181","author":"N Zander","year":"2019","unstructured":"Zander N, Sommer R, Sch\u00e4fer I et al (2019) Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees. Br J Dermatol 181(4):743\u2013748. https:\/\/doi.org\/10.1111\/bjd.17826","journal-title":"Br J Dermatol"},{"key":"2830_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15871","author":"F Russo","year":"2022","unstructured":"Russo F, Rizzo A, Santi F et al (2022) A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic dermatitis. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.15871","journal-title":"Int J Dermatol"},{"issue":"8","key":"2830_CR74","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/ccr3.2871","volume":"8","author":"A Al-Janabi","year":"2020","unstructured":"Al-Janabi A, Marsland AM (2020) Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: two case reports. Clin Case Rep 8(8):1458\u20131460. https:\/\/doi.org\/10.1002\/ccr3.2871","journal-title":"Clin Case Rep"},{"issue":"4","key":"2830_CR75","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jid.2017.11.020","volume":"138","author":"MGH Sanders","year":"2018","unstructured":"Sanders MGH, Pardo LM, Uitterlinden AG, Smith AM, Ginger RS, Nijsten T (2018) The genetics of seborrheic dermatitis: a candidate gene approach and pilot genome-wide association study. J Invest Dermatol 138(4):991\u2013993. https:\/\/doi.org\/10.1016\/j.jid.2017.11.020","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02830-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T09:03:27Z","timestamp":1712653407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02830-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02830-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RC has served as an advisory board member, consultant, and\/or investigator for AbbVie, Apogee Therapeutics, Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, FIDE, Galderma, Genentech, Incyte, Janssen, LEO Pharma, L\u2019Or\u00e9al, Nektar Therapeutics, Novan, Inc., Opsidio, Pfizer Inc., Regeneron, RAPT, Sanofi, and UCB. CHC has no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"100"}}